Gut microbiome and diabetic kidney disease: Insights from Mendelian randomization and genetic correlations

肠道微生物群与糖尿病肾病:来自孟德尔随机化和遗传相关性的启示

阅读:2

Abstract

The causal effects of specific gut microbiota (GM) on the development of diabetic kidney disease (DKD) have not yet been revealed. We employed independent single nucleotide polymorphisms from 196 gut bacterial taxa (N = 18,340) as instrumental variables in a 2-sample Mendelian randomization framework. DKD summary statistics were sourced from publicly accessible genome-wide association study databases, the FinnGen Consortium R9 publications, and the Juvenile Diabetes Research Foundation-funded collaborative research program. The analysis was conducted on outcome data from various sources using GM data as exposure. DKD outcomes from different sources were meta-analyzed based on 196 GM classifications. Furthermore, we evaluated the genetic association between specific GM populations and DKD by using the linkage disequilibrium score regression approach. Results showed Coprococcus2 (odds ratios [OR] = 0.8297, 95% confidence interval [CI]: 0.7427-0.9268, P = .0009) and Defluviitaleaceae (OR = 0.8802, 95% CI: 0.8121-0.9539, P = .0019) offer protection, while Bacteroidetes (OR = 1.1869, 95% CI: 1.0261-1.3729, P = .0211), Lachnoclostridium (OR = 1.1602, 95% CI: 1.0267-1.3111, P = .0172), and Veillonellaceae (OR = 1.0998, 95% CI: 1.0183-1.1879, P = .0154) increase risk. This study establishes a causal relationship between GM and DKD and highlights potential protective and risk-related microbial taxa.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。